Search research articles
Contact Us
Filters
Showing results (131-140 of 172) with videos related to
Page
of 18
Sort By:
Journal of the American Heart Association
|
February 23, 2018
High-Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long-Term Outcomes
Ayman Samman Tahhan, Pratik Sandesara, Salim S Hayek, et al.
Journal of the American Heart Association
|
December 8, 2023
Immune Activation Mediates the Association of Advanced Hepatic Fibrosis With Adverse Outcomes in Patients With Coronary Artery Disease
Vardhmaan Jain, Anurag Mehta, Terence B Lee, et al.
Journal of the American Heart Association
|
September 4, 2019
Low Educational Attainment is a Predictor of Adverse Outcomes in Patients With Coronary Artery Disease
Heval M Kelli, Anurag Mehta, Ayman S Tahhan, et al.
Atherosclerosis
|
September 7, 2016
Circulating progenitor cells and coronary microvascular dysfunction: Results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation - Coronary Vascular Dysfunction Study (WISE-CVD)
Girum Mekonnen, Salim S Hayek, Puja K Mehta, et al.
Trends in Cardiovascular Medicine
|
June 1, 2020
Management of Cardiovascular Disease During Coronavirus Disease (COVID-19) Pandemic
Sarju Ganatra, Sourbha S Dani, Sachin Shah, et al.
JAMA Pediatrics
|
September 6, 2017
Association of Serum Soluble Urokinase Receptor Levels With Progression of Kidney Disease in Children
Franz Schaefer, Howard Trachtman, Elke Wühl, et al.
The Journal of Clinical Investigation
|
February 8, 2019
uPAR isoform 2 forms a dimer and induces severe kidney disease in mice
Changli Wei, Jing Li, Brian D Adair, et al.
The New England Journal of Medicine
|
January 30, 2020
Soluble Urokinase Receptor and Acute Kidney Injury
Salim S Hayek, David E Leaf, Ayman Samman Tahhan, et al.
Journal of the American Heart Association
|
December 10, 2021
Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19
Michael Pan, Alexi Vasbinder, Elizabeth Anderson, et al.
JACC. Cardiooncology
|
January 13, 2025
SGLT2i and Primary Prevention of Cancer Therapy-Related Cardiac Dysfunction in Patients With Diabetes
Ammar W Bhatti, Rushin Patel, Sourbha S Dani, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 172) with videos related to
Sort By:
Page
of 18
Journal of the American Heart Association
|
February 23, 2018
High-Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long-Term Outcomes
Ayman Samman Tahhan, Pratik Sandesara, Salim S Hayek, et al.
Journal of the American Heart Association
|
December 8, 2023
Immune Activation Mediates the Association of Advanced Hepatic Fibrosis With Adverse Outcomes in Patients With Coronary Artery Disease
Vardhmaan Jain, Anurag Mehta, Terence B Lee, et al.
Journal of the American Heart Association
|
September 4, 2019
Low Educational Attainment is a Predictor of Adverse Outcomes in Patients With Coronary Artery Disease
Heval M Kelli, Anurag Mehta, Ayman S Tahhan, et al.
Atherosclerosis
|
September 7, 2016
Circulating progenitor cells and coronary microvascular dysfunction: Results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation - Coronary Vascular Dysfunction Study (WISE-CVD)
Girum Mekonnen, Salim S Hayek, Puja K Mehta, et al.
Trends in Cardiovascular Medicine
|
June 1, 2020
Management of Cardiovascular Disease During Coronavirus Disease (COVID-19) Pandemic
Sarju Ganatra, Sourbha S Dani, Sachin Shah, et al.
JAMA Pediatrics
|
September 6, 2017
Association of Serum Soluble Urokinase Receptor Levels With Progression of Kidney Disease in Children
Franz Schaefer, Howard Trachtman, Elke Wühl, et al.
The Journal of Clinical Investigation
|
February 8, 2019
uPAR isoform 2 forms a dimer and induces severe kidney disease in mice
Changli Wei, Jing Li, Brian D Adair, et al.
The New England Journal of Medicine
|
January 30, 2020
Soluble Urokinase Receptor and Acute Kidney Injury
Salim S Hayek, David E Leaf, Ayman Samman Tahhan, et al.
Journal of the American Heart Association
|
December 10, 2021
Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19
Michael Pan, Alexi Vasbinder, Elizabeth Anderson, et al.
JACC. Cardiooncology
|
January 13, 2025
SGLT2i and Primary Prevention of Cancer Therapy-Related Cardiac Dysfunction in Patients With Diabetes
Ammar W Bhatti, Rushin Patel, Sourbha S Dani, et al.
Page
of 18